Study of Long-term Safety, Efficacy Tolerability of BYM338 in Patients With Sporadic Inclusion Body Myositis
Clinical trial NCT02250443 · COMPLETED
Trial details
- NCT number
- NCT02250443
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-11
- Primary completion
- 2016-08-23
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.